Trial · NCT00808067
Adverse events1,414
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 1,414
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Neutropenia | Blood and lymphatic system disorders | Dabigatran 110 mg | 0 | 2,914 | |
| serious | Neutropenia | Blood and lymphatic system disorders | Dabigatran 150 mg | 1 | 2,937 | |
| serious | Polycythaemia | Blood and lymphatic system disorders | Dabigatran 110 mg | 1 | 2,914 | |
| serious | Polycythaemia | Blood and lymphatic system disorders | Dabigatran 150 mg | 0 | 2,937 | |
| serious | Thrombocytopenia | Blood and lymphatic system disorders | Dabigatran 110 mg | 5 | 2,914 | |
| serious | Thrombocytopenia | Blood and lymphatic system disorders | Dabigatran 150 mg | 5 | 2,937 | |
| serious | Acute coronary syndrome | Cardiac disorders | Dabigatran 110 mg | 2 | 2,914 | |
| serious | Acute coronary syndrome | Cardiac disorders | Dabigatran 150 mg | 6 | 2,937 | |
| serious | Acute left ventricular failure | Cardiac disorders | Dabigatran 110 mg | 0 | 2,914 | |
| serious | Acute left ventricular failure | Cardiac disorders | Dabigatran 150 mg | 1 | 2,937 | |
| serious | Acute myocardial infarction | Cardiac disorders | Dabigatran 110 mg | 1 | 2,914 | |
| serious | Acute myocardial infarction | Cardiac disorders | Dabigatran 150 mg | 0 | 2,937 | |
| serious | Angina pectoris | Cardiac disorders | Dabigatran 110 mg | 34 | 2,914 | |
| serious | Angina pectoris | Cardiac disorders | Dabigatran 150 mg | 36 | 2,937 | |
| serious | Angina unstable | Cardiac disorders | Dabigatran 110 mg | 2 | 2,914 | |
| serious | Angina unstable | Cardiac disorders | Dabigatran 150 mg | 13 | 2,937 | |
| serious | Aortic valve stenosis | Cardiac disorders | Dabigatran 110 mg | 1 | 2,914 | |
| serious | Aortic valve stenosis | Cardiac disorders | Dabigatran 150 mg | 1 | 2,937 | |
| serious | Arrhythmia | Cardiac disorders | Dabigatran 110 mg | 5 | 2,914 | |
| serious | Arrhythmia | Cardiac disorders | Dabigatran 150 mg | 4 | 2,937 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00808067/events?page=2